Skip to content

CARMEDIS

Active Private limited companyfounded 2001active for 24 yearsAvenue Victor Hugo 8, 1300 WavreKBO/BCE: BE 0476.506.956

Lifetime

20 annual accounts with figures on one time axis, 24 filings since 2002
peak of €558,517 in 2024
€317,485▼ 43.2%
peak of €274,637 in 2024
€139,543▼ 49.2%
peak of €878,826 in 2024
€697,870▼ 20.6%
€327,408▲ 736%
Board2 names since 2021
2 directors and 1 other
Documentsfilings and deeds
29-07-20262 days before the deadline
2025micro format
Gross margin from €558,517 to €317,485Result from €274,637 to €139,543Dividend €320,500Equity from €878,826 to €697,870Debts from €39,176 to €327,408

Key points

from the 2025 annual accounts

Equity

€697,870 ▼ 20.6%
878,8262024+139,543Profit-320,500Dividend697,8702025

CARMEDIS paid out €320,500 in dividends. That is 230% of the 2025 profit.

Liquidity

2.85 was 20.59 in 2024

Short-term debts rose from €39,165 to €327,396.

Filings

24 annual accounts since 2002
AprilJune31 JulyOctober20102020

The last five annual accounts were filed 2 to 65 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 20,149 companies had the same profile as CARMEDIS has now. Each dot stands for 51 companies, two years later.

95.0%
were still trading
4.7%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 20,149 companies, not a prediction for CARMEDIS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Board & ownership

Recent changes

(director) and (director) change roles Director discharge: · Director discharge: · General meeting of 31-07-2023 · Gazette deed
Purpose change · Amendment of the articles “A titre accessoire, la société peut accomplir toutes opérations immobilières dans le cadre du développement de…” (deed in French) · General meeting of 11-12-2014 · Gazette deed
Capital increase of €100,000 to €118,600 The capital rose from €18,600 to €118,600, with 538 new shares · General meeting of 18-12-2013 · Gazette deed
Incorporation published on 11-01-2002 · Gazette deed
All 39 events

Official details

Source: KBO
Status
Active since 28-12-2001Normal situation
Activity
“En assurant la gestion d'un centre médical ou d'un cabinet médical,en ce compris l'acquisition,la…” (deed in French)From the articles, 3 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €640,000estimated
€1.0m▲ 11.7%
Filing
Filed on 29-07-2026, 2 days before the end of the filing period
Financials

Insights on CARMEDIS

CARMEDIS files the micro format. That format states no turnover. The gross margin rose from €129,163 in 2006 to €317,485 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CARMEDIS

What is the company number of CARMEDIS?
The company number of CARMEDIS is 0476.506.956. The VAT number is the same number with BE in front: BE 0476.506.956.
Where is CARMEDIS based?
The registered office is at Avenue Victor Hugo 8, 1300 Wavre.Company details
What is the legal form of CARMEDIS?
CARMEDIS is a private limited company (BV).
When was CARMEDIS founded?
CARMEDIS was founded on 28-12-2001.
Is CARMEDIS still active?
Yes, CARMEDIS is an active enterprise in the KBO register.
What is the turnover of CARMEDIS?
The turnover in financial year 2025 is ≈ €640,000. This figure is estimated from the gross margin of €317,485 and 1,019 comparable companies of the same size. It probably lies between €440,000 and €930,000. It is a rough estimate.Financials
Is CARMEDIS profitable?
In financial year 2025, CARMEDIS made a profit of €139,543.
Where can I find the annual accounts of CARMEDIS?
CARMEDIS filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CARMEDIS due?
CARMEDIS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.